Exane Derivatives’s Northrop Grumman NOC Stock Holding History

Exane Derivatives’s Portfolio NOC Stock Details NOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$28.7K	Sell	60 -106	-64%	-$48.7K	0.02%	347
2022 Q1	$74.2K	Sell	166 -14	-8%	-$5.78K	0.02%	511
2021 Q4	$69.7K	Sell	180 -1,147	-86%	-$427K	0.02%	472
2021 Q3	$478K	Buy	1,327 +888	+202%	+$321K	0.11%	196
2021 Q2	$161K	Buy	439 +218	+99%	+$78.5K	0.04%	451
2021 Q1	$71.5K	Hold	221	–	–	0.02%	474
2020 Q4	$67.3K	Buy	221 +219	+10,950%	+$67K	0.02%	435
2020 Q3	$631	Hold	2	–	–	﹤0.01%	661
2020 Q2	$615	Hold	2	–	–	﹤0.01%	593
2020 Q1	$605	Sell	2 -1,664	-100%	-$579K	﹤0.01%	574
2019 Q4	$633K	Sell	1,666 -38	-2%	-$13.4K	0.12%	141
2019 Q3	$639K	Buy	+1,704	New	+$603K	0.11%	142
2018 Q1	–	Sell	-1	Closed	-$307	–	650
2017 Q4	$307	Hold	1	–	–	﹤0.01%	516
2017 Q3	$288	Sell	1 -6	-86%	-$1.61K	﹤0.01%	483
2017 Q2	$1.8K	Sell	7 -39	-85%	-$9.76K	﹤0.01%	453
2017 Q1	$10.9K	Buy	+46	New	+$10.9K	﹤0.01%	348

Other funds holding NOC

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Exane Derivatives's NOC Position: Q2 2022 in Review

Exane Derivatives reduced its Northrop Grumman (NOC) stake by 64% in Q2 2022, selling an estimated $48.7K and leaving 60 shares worth $28.7K. The position accounts for 0.02% of the portfolio, ranked #347.

Exane Derivatives first reported a position in NOC in Q1 2017 and has held it in 16 quarters since. The position peaked at $639K in Q3 2019. 1,380 funds tracked by Wall St. Rank hold NOC as of Q2 2022.

Exane Derivatives held 60 shares of Northrop Grumman worth $28.7K as of Q2 2022.
Exane Derivatives sold 106 Northrop Grumman shares in Q2 2022, an estimated $48.7K.
Northrop Grumman made up 0.02% of Exane Derivatives's portfolio in Q2 2022, its #347 holding.
Exane Derivatives first reported a position in Northrop Grumman in Q1 2017 and has held it in 16 quarters since.
Exane Derivatives's Northrop Grumman position peaked at $639K in Q3 2019.
1,380 funds tracked by Wall St. Rank held Northrop Grumman as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.